Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Efficacy of a flexible quit date versus an a priori quit date approach to smoking cessation: a cross-study analysis.

Hughes JR, Russ CI, Arteaga CE, Rennard SI.

Addict Behav. 2011 Dec;36(12):1288-91. doi: 10.1016/j.addbeh.2011.08.001. Epub 2011 Aug 5.

PMID:
21872998
2.

Efficacy of varenicline to prompt quit attempts in smokers not currently trying to quit: a randomized placebo-controlled trial.

Hughes JR, Rennard SI, Fingar JR, Talbot SK, Callas PW, Fagerstrom KO.

Nicotine Tob Res. 2011 Oct;13(10):955-64. doi: 10.1093/ntr/ntr103. Epub 2011 Jun 7.

3.

Nicotine preloading: the importance of a pre-cessation reduction in smoking behavior.

Rose JE.

Psychopharmacology (Berl). 2011 Oct;217(3):453-4. doi: 10.1007/s00213-011-2350-0. Epub 2011 Jun 4. No abstract available.

PMID:
21643677
4.

Varenicline for smoking cessation: nausea severity and variation in nicotinic receptor genes.

Swan GE, Javitz HS, Jack LM, Wessel J, Michel M, Hinds DA, Stokowksi RP, McClure JB, Catz SL, Richards J, Zbikowski SM, Deprey M, McAfee T, Conti DV, Bergen AW.

Pharmacogenomics J. 2012 Aug;12(4):349-58. doi: 10.1038/tpj.2011.19. Epub 2011 May 24.

5.

Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates.

Hajek P, McRobbie HJ, Myers KE, Stapleton J, Dhanji AR.

Arch Intern Med. 2011 Apr 25;171(8):770-7. doi: 10.1001/archinternmed.2011.138.

PMID:
21518946
6.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD006103.

PMID:
21328282
7.

New methods for tobacco dependence treatment research.

Baker TB, Mermelstein R, Collins LM, Piper ME, Jorenby DE, Smith SS, Christiansen BA, Schlam TR, Cook JW, Fiore MC.

Ann Behav Med. 2011 Apr;41(2):192-207. doi: 10.1007/s12160-010-9252-y. Review. Erratum in: Ann Behav Med. 2011 Aug;42(1):139.

8.

A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessation.

Faessel HM, Obach RS, Rollema H, Ravva P, Williams KE, Burstein AH.

Clin Pharmacokinet. 2010 Dec;49(12):799-816. doi: 10.2165/11537850-000000000-00000. Review.

PMID:
21053991
9.

The safety and efficacy of varenicline in cocaine using smokers maintained on methadone: a pilot study.

Poling J, Rounsaville B, Gonsai K, Severino K, Sofuoglu M.

Am J Addict. 2010 Sep-Oct;19(5):401-8. doi: 10.1111/j.1521-0391.2010.00066.x.

10.

Nicotine addiction.

Benowitz NL.

N Engl J Med. 2010 Jun 17;362(24):2295-303. doi: 10.1056/NEJMra0809890. Review. No abstract available.

11.

Strategies for smoking cessation: what is new and what works?

Cummings KM, Mahoney MC.

Expert Rev Respir Med. 2008 Apr;2(2):201-13. doi: 10.1586/17476348.2.2.201.

PMID:
20477249
12.

Quantitative assessment of exposure-response relationships for the efficacy and tolerability of varenicline for smoking cessation.

Ravva P, Gastonguay MR, French JL, Tensfeldt TG, Faessel HM.

Clin Pharmacol Ther. 2010 Mar;87(3):336-44. doi: 10.1038/clpt.2009.282. Epub 2010 Jan 27.

PMID:
20107434
13.

The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats.

O'Connor EC, Parker D, Rollema H, Mead AN.

Psychopharmacology (Berl). 2010 Feb;208(3):365-76. doi: 10.1007/s00213-009-1739-5. Epub 2009 Dec 5.

PMID:
19967529
14.

A longer course of varenicline therapy improves smoking cessation rates.

Lee JH, Jones PG, Bybee K, O'Keefe JH.

Prev Cardiol. 2008 Fall;11(4):210-4. doi: 10.1111/j.1751-7141.2008.00003.x. Review.

15.

Cigarette smoking among adults--United States, 2007.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2008 Nov 14;57(45):1221-6. Erratum in: MMWR Morb Mortal Wkly Rep. 2008 Nov 28;57(47):1281.

16.

Sex differences in long-term smoking cessation rates due to nicotine patch.

Perkins KA, Scott J.

Nicotine Tob Res. 2008 Jul;10(7):1245-50. doi: 10.1080/14622200802097506. Review.

PMID:
18629735
17.

A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation.

Becker KM, Rose JE, Albino AP.

Nicotine Tob Res. 2008 Jul;10(7):1139-48. doi: 10.1080/14622200802123294.

PMID:
18629723
18.

Ecological momentary assessment.

Shiffman S, Stone AA, Hufford MR.

Annu Rev Clin Psychol. 2008;4:1-32. Review.

PMID:
18509902
19.

Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion.

Patterson F, Schnoll RA, Wileyto EP, Pinto A, Epstein LH, Shields PG, Hawk LW, Tyndale RF, Benowitz N, Lerman C.

Clin Pharmacol Ther. 2008 Sep;84(3):320-5. doi: 10.1038/clpt.2008.57. Epub 2008 Apr 2. No abstract available.

PMID:
18388868
20.

Nicotine patch therapy prior to quitting smoking: a meta-analysis.

Shiffman S, Ferguson SG.

Addiction. 2008 Apr;103(4):557-63. doi: 10.1111/j.1360-0443.2008.02138.x. Review.

PMID:
18339101

Supplemental Content

Support Center